Context Therapeutics Inc. (CNTX) — DEF 14A Filings
All DEF 14A filings from Context Therapeutics Inc.. Browse 3 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (3)
-
Context Therapeutics Inc. Files 2025 Proxy Statement
— Apr 15, 2025 Risk: low
Context Therapeutics Inc. filed its definitive proxy statement on April 15, 2025, for its annual meeting on June 12, 2025. The filing details executive compensa -
Context Therapeutics Inc. files 2024 Proxy Statement
— Jul 24, 2024 Risk: low
Context Therapeutics Inc. filed a definitive proxy statement (DEF 14A) on July 24, 2024, for its annual meeting on September 17, 2024. The company, incorporated -
Context Therapeutics Inc. Announces 2024 Annual Meeting of Stockholders
— Apr 26, 2024 Risk: low
Context Therapeutics Inc. (CNTX) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Context Therapeutics Inc. will hold its 2024 Annual Meeting o
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX